On this page

Impetigo Overview - Skin's Sticky Situation

  • Definition: Highly contagious, superficial bacterial skin infection, primarily affecting the epidermis.
  • Etiology:
    • Staphylococcus aureus (most common, ~80%), often MRSA.
    • Streptococcus pyogenes (Group A Strep, GAS).
    • Mixed infections are also common.
  • Epidemiology:
    • Predominantly affects children (peak 2-5 yrs).
    • More prevalent in summer/fall; favors warm, humid climates.
    • Risk factors: Poor hygiene, pre-existing skin trauma (e.g., insect bites, eczema, abrasions).
    • Transmission: Highly contagious via direct contact.
  • Pathophysiology: Bacteria invade compromised skin → proliferate within epidermis → produce toxins (e.g., exfoliative toxins by S. aureus causing bullae in bullous impetigo).

Impetigo: Non-bullous, Bullous, and Ecthyma

⭐ Impetigo is the most common bacterial skin infection in children worldwide.

Clinical Presentation - Crusts, Bullae, Ulcers

Impetigo types: nonbullous, bullous, ecthyma

FeatureNon-bullous Impetigo (Impetigo Contagiosa, ~70% cases)Bullous Impetigo
EtiologyPrimarily S. aureus; also S. pyogenes, mixed.Exclusively S. aureus (exfoliative toxins ETA, ETB)
Key LesionVesicles/pustules → rupture → Honey-colored crusts.Flaccid bullae (1-2 cm; clear/cloudy fluid) → rupture → thin, varnish-like crust or collarette of scale.
SitesFace (perioral, perinasal), extremities.Trunk, extremities, intertriginous areas, diaper area (neonates).
OtherPruritus common. Regional lymphadenopathy may occur.Nikolsky sign usually negative. Less surrounding erythema.
  • Ecthyma:
    • Deeper, ulcerative form extending into the dermis.
    • Presents as "punched-out" ulcers covered by thick, adherent crusts.
    • Heals with scarring.
    • Etiology: Often S. pyogenes; S. aureus can be involved.
    • Common on lower extremities, sites of neglect/poor hygiene.

Diagnosis & DDx - Spotting the Signs

Diagnosis: Primarily clinical, based on characteristic lesions.

Diagnostic Pathway:

Investigations (if atypical, widespread, recurrent, MRSA suspected, or Rx failure):

  • Gram stain: Gram-positive cocci (clusters/chains). From moist lesion base or bulla fluid.
  • Culture & Sensitivity: Identifies organism & guides Rx; crucial for MRSA.

Differential Diagnosis (DDx):

  • Non-bullous Impetigo:
    • Herpes simplex (grouped vesicles, often painful)
    • Tinea corporis (annular, central clearing, active scaly border)
    • Atopic dermatitis (eczematous plaques, intense pruritus)
    • Scabies (burrows, intense nocturnal pruritus)
  • Bullous Impetigo:
    • Bullous insect bites
    • Bullous pemphigoid (tense bullae, elderly)
    • Epidermolysis bullosa (inherited, friction-induced)
    • Burns
  • Ecthyma:
    • Cutaneous leishmaniasis
    • Vasculitic ulcers
    • Pyoderma gangrenosum

⭐ While diagnosis is usually clinical, bacterial culture is crucial for identifying MRSA and guiding antibiotic therapy in complicated cases.

Management & Complications - Healing & Hazards

  • General Measures: Gentle cleansing, crust removal. Good personal hygiene, hand washing. Avoid scratching. School/daycare exclusion until lesions dry or 24h post-antibiotics.
  • Topical Therapy (for limited, localized non-bullous or few bullous lesions):
    • Mupirocin 2% ointment/cream (TID for 5-7 days).
    • Retapamulin 1% ointment (BID for 5 days).
    • Fusidic acid 2% cream (TID for 5-7 days).
  • Systemic Antibiotics (for extensive disease, >5 lesions, ecthyma, bullous impetigo, oral cavity involvement, systemic symptoms, or outbreaks; typically 7 days):
    • Standard: Dicloxacillin, Cephalexin.
    • MRSA suspected/confirmed: Clindamycin, Doxycycline (contraindicated <8 yrs), TMP-SMX. 📌 Mnemonic: "Try Drugs for Clean MRSA" (TMP-SMX, Doxycycline/Minocycline, Clindamycin, Linezolid).
  • Complications:
    • Post-Streptococcal Glomerulonephritis (PSGN): After S. pyogenes impetigo; latent period 1-3 weeks. Antibiotics may not prevent.
    • Cellulitis, lymphangitis.
    • Staphylococcal Scalded Skin Syndrome (SSSS) (with toxin-producing S. aureus).
    • Scarlet fever (with GAS).
    • Rheumatic fever: NOT a complication of cutaneous streptococcal infections.

⭐ Unlike streptococcal pharyngitis, antibiotic treatment of streptococcal impetigo does not reliably prevent the development of post-streptococcal glomerulonephritis (PSGN).

High-Yield Points - ⚡ Biggest Takeaways

  • Impetigo is a highly contagious, superficial bacterial skin infection, common in children.
  • Predominantly caused by Staphylococcus aureus; also Streptococcus pyogenes.
  • Non-bullous impetigo (most common) shows honey-colored, stuck-on crusts.
  • Bullous impetigo is caused by S. aureus exfoliative toxin A, forming flaccid bullae.
  • Typically affects the face (perioral, perinasal) and extremities.
  • Post-streptococcal glomerulonephritis (PSGN) can follow streptococcal impetigo; rheumatic fever does not.
  • Management includes topical mupirocin for localized cases or systemic antibiotics for extensive disease.

Practice Questions: Impetigo

Test your understanding with these related questions

Which organism is most associated with neonatal meningitis and skin rash?

1 of 5

Flashcards: Impetigo

1/10

Degenerated acantholytic cells are seen on the Tzank smear in SSSS, Bullous impetigo and Darier disease at the level of stratum _____

TAP TO REVEAL ANSWER

Degenerated acantholytic cells are seen on the Tzank smear in SSSS, Bullous impetigo and Darier disease at the level of stratum _____

granulosum

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial